Literature DB >> 30806445

Endothelial lesion and complement activation in patients with Scleroderma Renal Crisis.

Ney Arencibia Pérez1, María Luisa Agüera Morales1, Rafael Sánchez Sánchez2, Rosa María Ortega Salas2, Rafael Ángel Fernández de la Puebla3, Mario Espinosa Hernández1.   

Abstract

In kidney biopsies reviews, scleroderma renal crisis (SRC) is characterized by vascular endothelial injuries, C4d deposits on peritubular vessels, and acute and chronic injuries coexisting on the same biopsy. The clinical signs of thrombotic microangiopathy (TMA) are described in systemic sclerosis (SSc), nevertheless, it has not been related to acute injuries described on kidney biopsies. We report a case of SRC in a patient with scleroderma-dermatomyositis overlap syndrome, which also showed clinical and histopathological data of TMA. On fundus examination, a severe acute hypertensive retinopathy was found. The kidney biopsy showed severe endothelial damage with widening of mucoid cells at the level of the intima, focal concentric proliferation on most small arterioles, and C3, C4d, and IgM deposits along the capillary walls. The genetic study of complement only showed the presence of membrane cofactor protein (MCP) risk haplotypes, without other genetic complement disorders. We understand that in a patient with TMA and SSc, the kidney damage would be fundamentally endothelial and of an acute type; moreover, we would observe clear evidence of complement activation. Once further studies correlate clinical-analytical data with anatomopathological studies, it is likely that we will be forced to redefine the SRC concept, focusing on the relationship between acute endothelial damage and complement activation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30806445      PMCID: PMC6979577          DOI: 10.1590/2175-8239-JBN-2018-0202

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  11 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Polymyositis and dermatomyositis (second of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

3.  Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls.

Authors:  Loïc Guillevin; Alice Bérezné; Raphaèle Seror; Luis Teixeira; Jacques Pourrat; Alfred Mahr; Eric Hachulla; Christian Agard; Jean Cabane; Philippe Vanhille; Jean-Robert Harle; Isabelle Deleveaux; Luc Mouthon
Journal:  Rheumatology (Oxford)       Date:  2011-11-15       Impact factor: 7.580

Review 4.  Scleroderma and the kidney.

Authors:  J F Donohoe
Journal:  Kidney Int       Date:  1992-02       Impact factor: 10.612

5.  Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.

Authors:  A Bohan; J B Peter; R L Bowman; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

6.  Kidney disease other than renal crisis in patients with diffuse scleroderma.

Authors:  Virginia D Steen; Aijaz Syzd; John P Johnson; Arthur Greenberg; Thomas A Medsger
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

7.  Long-term outcomes of scleroderma renal crisis.

Authors:  V D Steen; T A Medsger
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

Review 8.  Renal complications and scleroderma renal crisis.

Authors:  C P Denton; G Lapadula; L Mouthon; U Müller-Ladner
Journal:  Rheumatology (Oxford)       Date:  2009-06       Impact factor: 7.580

9.  Scleroderma renal crisis: patient characteristics and long-term outcomes.

Authors:  H Penn; A J Howie; E J Kingdon; C C Bunn; R J Stratton; C M Black; A Burns; C P Denton
Journal:  QJM       Date:  2007-06-29

10.  Eculizumab in secondary atypical haemolytic uraemic syndrome.

Authors:  Teresa Cavero; Cristina Rabasco; Antía López; Elena Román; Ana Ávila; Ángel Sevillano; Ana Huerta; Jorge Rojas-Rivera; Carolina Fuentes; Miquel Blasco; Ana Jarque; Alba García; Santiago Mendizabal; Eva Gavela; Manuel Macía; Luis F Quintana; Ana María Romera; Josefa Borrego; Emi Arjona; Mario Espinosa; José Portolés; Carolina Gracia-Iguacel; Emilio González-Parra; Pedro Aljama; Enrique Morales; Mercedes Cao; Santiago Rodríguez de Córdoba; Manuel Praga
Journal:  Nephrol Dial Transplant       Date:  2017-03-01       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.